Post

Researchers project that further scaling up use of HIV prevention drug lenacapavir has the potential to bring the annual population-wide HIV incidence rate in South Africa to less than 0.1 percent, the virtual elimination threshold, as early as 2039, write CSIS experts. Read: https://bit.ly/4BoQzjC